Author name: PRNewswire

TORONTO, July 27, 2025 /PRNewswire/ — The Alzheimer’s Association® will present 10 scientific awards at the Alzheimer’s Association International Conference® 2025 (AAIC®), recognizing researchers for their expertise, noteworthy achievements and innovative contributions to the field of Alzheimer’s disease and dementia science. “The Alzheimer’s Association envisions a world without Alzheimer’s and all other dementia, and these leaders […]

TORONTO, July 27, 2025 /PRNewswire/ — The Alzheimer’s Association® honored the Fred and Barbara Erb Family Foundation with the Jerome H. Stone Philanthropy Award for Alzheimer’s Research at the Alzheimer’s Association International Conference ® 2025 (AAIC®) for their deep and unwavering contributions to advancing progress in Alzheimer’s science. Fred A. Erb grew his family’s firm

NEW YORK, July 27, 2025 /PRNewswire/ — Pomerantz LLP announces that a class action lawsuit has been filed against Biohaven Ltd. (“Biohaven” or the “Company”) (NYSE: BHVN) and certain officers.  The class action, filed in the United States District Court for the District of Connecticut, and docketed under 25-cv-01120, is on behalf of a class consisting of

NEW YORK, July 27, 2025 /PRNewswire/ — Pomerantz LLP announces that a class action lawsuit has been filed against Western Asset Management Company, LLC (“WAMCO”), Franklin Resources, Inc., and Stephen Kenneth Leech, II (“Leech”) (together, the “Defendants”), on behalf of investors in the shares of the “Western Asset US Core Bond Fund” mutual fund classes

NEW YORK, July 27, 2025 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Ultragenyx Pharmaceutical Inc. (“Ultragenyx” or the “Company”) (NASDAQ: RARE).  Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.   The investigation concerns whether Ultragenyx and certain of its officers and/or directors have engaged in securities fraud

NEW YORK, July 27, 2025 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Neogen Corporation (“Neogen” or the “Company”) (NASDAQ: NEOG).  Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.   The investigation concerns whether Neogen and certain of its officers and/or directors have engaged in securities fraud or other

NEW YORK, July 27, 2025 /PRNewswire/ — Pomerantz LLP announces that a class action lawsuit has been filed against Petco Health and Wellness Company, Inc. (“Petco” or the “Company”) (NASDAQ: WOOF) and certain officers.  The class action, filed in the United States District Court for the Southern District of California, and docketed under 25-cv-01667, is on behalf

NEW YORK, July 27, 2025 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Jasper Therapeutics, Inc. (“Jasper” or the “Company”) (NASDAQ: JSPR). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.  The investigation concerns whether Jasper and certain of its officers and/or directors have engaged in securities fraud or other unlawful